Evoke Pharma Inc. (EVOK): Thank you for your reply, much appreciat...

S&P 500

US TECH 100

Dow Jones

Brent Oil

Bitcoin

Evoke Pharma Inc. (EVOK)

Reply Private New

Keep Last Read

Next 10 Prev Next

Send PM Follow Ignore

Followers	33
Posts	2023
Boards Moderated	0
Alias Born	06/30/2011

Re: hp435 post# 1202

Wednesday, 03/15/2017 7:20:13 PM

Wednesday, March 15, 2017 7:20:13 PM

Thank you for your reply, much appreciated.

Keep Last Read

Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

1D
1M
3M
6M
1Y
5Y

Detailed Quote

Recent EVOK News

Form 8-K - Current report • Edgar (US Regulatory) • 08/16/2024 11:00:08 AM
Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 08/13/2024 09:01:13 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/13/2024 12:20:07 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/13/2024 12:15:18 PM
Evoke Pharma, Inc. Reports Second Quarter 2024 Financial Results • GlobeNewswire Inc. • 08/13/2024 12:00:03 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/08/2024 09:11:22 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/08/2024 08:51:18 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/08/2024 08:48:45 PM
Evoke Pharma, Inc. Supports Gastroparesis Awareness Month • GlobeNewswire Inc. • 08/08/2024 12:30:37 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/01/2024 11:00:09 AM
Evoke Pharma, Inc. Announces Reverse Stock Split • GlobeNewswire Inc. • 07/30/2024 12:30:09 PM
Form 8-K - Current report • Edgar (US Regulatory) • 06/20/2024 11:01:20 AM
Evoke Pharma Reports Commercial Strategy Progress & Positive Momentum for GIMOTI • GlobeNewswire Inc. • 06/17/2024 12:30:20 PM
Form 8-K - Current report • Edgar (US Regulatory) • 06/07/2024 12:00:09 PM
Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 05/30/2024 10:09:14 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/24/2024 09:02:13 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/24/2024 08:56:10 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/24/2024 08:53:59 PM
Evoke Pharma to Present Additional GIMOTI Healthcare Utilization Data Focused on Gastroparesis Care Insights in Women at 2024 Digestive Disease Week (DDW) Conference • GlobeNewswire Inc. • 05/16/2024 08:02:24 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/14/2024 08:20:33 PM
Evoke Pharma Reports First Quarter 2024 Financial Results • GlobeNewswire Inc. • 05/14/2024 08:15:37 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/14/2024 08:15:18 PM
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 05/14/2024 08:05:54 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/14/2024 08:00:15 PM

More EVOK News

InvestorsHub NewsWire

HealthLynked Corp. Announces Second Quarter and First Half 2024 Results: Continued Cost Reductions Set the Stage for Strategic Shift to App-Based Technology Services • HLYK • Aug 16, 2024 8:00 AM

PickleJar Announces Official Name Change and New Ticker Symbol • NREG • Aug 15, 2024 2:23 PM

VAYK's Q2 Profit Added to Accumulated Net Profit of Over $2.2 Million In 18 Months • VAYK • Aug 15, 2024 9:07 AM

Swifty Global Reports Strong Q2 Performance and Prepares for Major Exchange Uplisting • DRCR • Aug 15, 2024 9:04 AM

Mayback's Global Entertainment Signs Global Distribution Agreement with Children's Media Studio • AHRO • Aug 15, 2024 8:45 AM

POET Technologies Reports Second Quarter 2024 Financial Results • POET • Aug 15, 2024 8:04 AM

Start posting your company's news

Only $200 per official company press release!

InvestorsHub community

Register for free to join our community of investors and share your ideas

You'll also get access to streaming quotes, interactive charts, trades, portfolio, live options flow